Loading...
XNYSCHD
Market cap26bUSD
Dec 26, Last price  
106.74USD
1D
0.26%
1Q
2.25%
Jan 2017
141.55%
Name

Church & Dwight Co Inc

Chart & Performance

D1W1MN
XNYS:CHD chart
P/E
34.61
P/S
4.46
EPS
3.08
Div Yield, %
1.02%
Shrs. gr., 5y
-0.25%
Rev. gr., 5y
7.19%
Revenues
5.87b
+9.16%
1,462,062,0001,736,506,0001,945,661,0002,220,940,0002,422,398,0002,520,922,0002,589,220,0002,749,300,0002,921,900,0003,194,300,0003,297,600,0003,394,800,0003,493,100,0003,776,200,0004,145,900,0004,357,700,0004,895,800,0005,190,100,0005,375,600,0005,867,900,000
Net income
756m
+82.56%
88,808,000122,906,000138,927,000169,025,000195,174,000243,533,000270,717,000309,600,000349,800,000394,400,000413,900,000410,400,000459,000,000743,400,000568,600,000615,900,000785,900,000827,500,000413,900,000755,600,000
CFO
1.03b
+16.43%
194,888,000190,107,000186,444,000248,677,000336,167,000400,949,000428,482,000437,800,000523,600,000499,600,000540,300,000606,100,000655,300,000681,500,000763,600,000864,500,000990,300,000993,800,000885,200,0001,030,599,999
Dividend
Aug 15, 20240.28375 USD/sh
Earnings
Jan 31, 2025

Profile

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
IPO date
Mar 17, 1980
Employees
5,250
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
5,867,900
9.16%
5,375,600
3.57%
5,190,100
6.01%
Cost of revenue
4,932,900
4,887,800
4,216,200
Unusual Expense (Income)
NOPBT
935,000
487,800
973,900
NOPBT Margin
15.93%
9.07%
18.76%
Operating Taxes
211,800
109,400
204,200
Tax Rate
22.65%
22.43%
20.97%
NOPAT
723,200
378,400
769,700
Net income
755,600
82.56%
413,900
-49.98%
827,500
5.29%
Dividends
(266,500)
(255,000)
(247,500)
Dividend yield
1.14%
1.28%
0.97%
Proceeds from repurchase of equity
(300,100)
299,400
BB yield
1.28%
-1.17%
Debt
Debt current
203,800
74,000
952,200
Long-term debt
2,552,000
2,751,400
1,757,300
Deferred revenue
(745,100)
Other long-term liabilities
171,600
315,400
1,077,400
Net debt
2,399,300
2,542,400
2,459,800
Cash flow
Cash from operating activities
1,030,600
885,200
993,800
CAPEX
(223,500)
(178,800)
(118,800)
Cash from investing activities
(234,300)
(728,600)
(682,000)
Cash from financing activities
(725,600)
(120,900)
(252,100)
FCF
386,400
254,200
729,800
Balance
Cash
344,500
270,300
240,600
Long term investments
12,000
12,700
9,100
Excess cash
63,105
14,220
Stockholders' equity
6,278,800
5,789,000
5,590,600
Invested Capital
6,544,795
6,457,580
6,125,100
ROIC
11.12%
6.01%
13.07%
ROCE
12.72%
6.75%
14.18%
EV
Common stock shares outstanding
247,600
246,300
249,600
Price
94.56
17.31%
80.61
-21.36%
102.50
17.51%
Market cap
23,413,056
17.92%
19,854,243
-22.40%
25,584,000
16.29%
EV
25,812,356
22,396,643
28,043,800
EBITDA
1,132,100
706,800
1,193,000
EV/EBITDA
22.80
31.69
23.51
Interest
110,900
89,600
54,500
Interest/NOPBT
11.86%
18.37%
5.60%